Discovery Biology - Assay Development and HTS
InSymbiosis has a wealth of experience in early phase drug discovery. Our expertise in assay development and high-throughput screening (HTS) enables us to take discovery projects from the cloning of the target through HTS into lead optimization.
Drug Target Cloning and Expression
- Cloning and expression in bacterial, yeast and mammalian systems
- Custom cell line generation and characterization
- Protein purification and characterization
- Large scale protein production
- Cell culture scale up and membrane production
Assay Development
- Biochemical:
- Direct enzyme activity (kinase, phosphatase, protease)
- Immunoassays (ELISA and ELISA conversions)
- Receptor binding (GPCRs, RTKs, ion channels)
- Protein-protein interactions
- Biacore (SPR) technology (label-free study of biomolecular interactions)
- Cell based assays:
- Second messenger (e.g. cAMP) for GPCRs
- Patch clamp electrophysiology for ion channels
- Gene reporter
- Cell proliferation, viability, cytotoxicty
- Apoptosis
- Cell motility, invasion
- FACS methods
High Throughput Screening
Automated Planar Patch Clamp For Ion Channels
- Pre-validated (e.g. hERG) and custom assays available
Compound Libraries
- Commercial library, collection of plant extracts, synthetic & commercial compounds, and known drug molecules
- Design and generation of small molecule libraries and peptides/peptide mimetics
Please see our Drug Discovery brochure for more details or Contact Us.
